Nebula Research & Development’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,069
Closed -$2.46M 791
2025
Q2
$2.46M Buy
6,069
+2,254
+59% +$942K 0.21% 142
2025
Q1
$1.9M Sell
3,815
-3,467
-48% -$1.88M 0.18% 180
2024
Q4
$3.79M Buy
7,282
+2,415
+50% +$1.33M 0.44% 14
2024
Q3
$3.01M Sell
4,867
-247
-5% -$146K 0.36% 38
2024
Q2
$2.83M Buy
5,114
+3,801
+289% +$2.18M 0.46% 2
2024
Q1
$763K Sell
1,313
-489
-27% -$274K 0.16% 217
2023
Q4
$956K Buy
1,802
+1,110
+160% +$537K 0.29% 82
2023
Q3
$350K Buy
+692
New +$369K 0.18% 230

Other funds holding TMO

Nebula Research & Development's TMO Position: Q3 2025 in Review

Nebula Research & Development sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 6,069 shares — an estimated $2.46M sold.

Nebula Research & Development first reported a position in TMO in Q3 2023 and held it in 8 quarters. The position peaked at $3.79M in Q4 2024. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Nebula Research & Development reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 6,069 Thermo Fisher Scientific shares in Q3 2025, an estimated $2.46M.
  • Nebula Research & Development first reported a position in Thermo Fisher Scientific in Q3 2023 and held it in 8 quarters.
  • Nebula Research & Development's Thermo Fisher Scientific position peaked at $3.79M in Q4 2024.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.